Home NDC 42952-101 I-MAX EXCELLENCE
Product NDC 42952-101
11-digit product format 429520101
Labeler code 42952
Product ID 42952-101_98fc49ff-0f37-48e8-99e7-4060418c5aca
Type HUMAN OTC DRUG
Nonproprietary name AVOBENZONE OCTINOXATE OXYBENZONE
Dosage form LOTION
Route TOPICAL
Labeler MAXLIFE USA, INC.
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2012-03-15
Marketing end 0000-00-00
Substance AVOBENZONE; OCTINOXATE; OXYBENZONE
Active strength 3 g/100mL; g/100mL; g/100mL
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 42952-101-12 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 42952-101-12 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 42952-101-12 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 42952-101-12 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 42952-101-12 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 42952-101-12 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 42952-101-12 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 42952-101-12 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 42952-101-12 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 42952-101-12 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 42952-101-12 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 42952-101-12 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 42952-101-12 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 42952-101-12 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 42952-101-12 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 42952-101-12 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 42952-101-12 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 42952-101-12 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 42952-101-12 8dfbde2a14a4…c9ff85d89658…
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42952-101-12 I-MAX EXCELLENCE 59 mL in 1 BOTTLE LOTION 59 9
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AVOBENZONE ACTIVE INGREDIENT G63QQF2NOX I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 OXYBENZONE ACTIVE INGREDIENT 95OOS7VE0Y I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 AVOBENZONE ACTIVE MOIETY G63QQF2NOX I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 OXYBENZONE ACTIVE MOIETY 95OOS7VE0Y I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 ALKYL (C12-15) BENZOATE INACTIVE INGREDIENT A9EJ3J61HQ I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 ALPHA-TOCOPHEROL ACETATE INACTIVE INGREDIENT 9E8X80D2L0 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 CARBOMER INTERPOLYMER TYPE A (55000 MPA.S) INACTIVE INGREDIENT 59TL3WG5CO I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 CETYL PHOSPHATE INACTIVE INGREDIENT VT07D6X67O I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 ETHYLHEXYLGLYCERIN INACTIVE INGREDIENT 147D247K3P I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 MAGNESIUM ALUMINUM SILICATE INACTIVE INGREDIENT 6M3P64V0NC I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 STEARETH-20 INACTIVE INGREDIENT L0Q8IK9E08 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 STEARYL ALCOHOL INACTIVE INGREDIENT 2KR89I4H1Y I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 TETRAHEXYLDECYL ASCORBATE INACTIVE INGREDIENT 9LBV3F07AZ I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6 WATER INACTIVE INGREDIENT 059QF0KO0R I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42952-101 I-MAX EXCELLENCE (AVOBENZONE OCTINOXATE OXYBENZONE) LOTION [MAXLIFE USA, INC.] 9 Legacy NDC, 1 package rows 20181108_0a654c5f-32c0-4599-91c3-1f17877aa8cb.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 42952-101-12 42952010112 59 mL in 1 BOTTLE 59 ml Historical